Physician profile
Vas Devan
NPI 1619967767
$13,062.72
in general payments reported to CMS, 2019-2025
36 companies · $2,245 in 2025
The $2,245 reported for 2025 was more than what 78% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,472 · 2020: $1,708 · 2021: $1,715 · 2022: $1,879 · 2023: $1,740 · 2024: $2,303 · 2025: $2,245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,209 · Education: $78.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,209.29 |
| Education | $78.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $3,643.99 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $1,974.11 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Regeneron Healthcare Solutions, INC. | $1,419.05 | 2019-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $862.74 | 2019-2025 | Ofev, Jascayd |
| Harmony Biosciences LLC | $788.46 | 2020-2025 | Wakix |
| Mylan Specialty L.P. | $492.03 | 2019-2024 | Yupelri |
| Genzyme Corporation | $411.78 | 2019-2024 | |
| Insmed, INC. | $333.54 | 2021-2025 | Arikayce |
| Philips North America LLC | $309.53 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $286.68 | 2019-2025 | Uptravi, Opsumit |
| Inspire Medical Systems, INC. | $273.79 | 2024-2025 | Inspire |
| Grifols USA, LLC | $270.70 | 2019-2025 | Prolastin-C Liquid |
| Electromed, INC. | $242.41 | 2021-2025 | Smartvest |
| Takeda Pharmaceuticals U.S.A., INC. | $236.11 | 2021-2025 | Glassia |
| Genentech USA, INC. | $230.78 | 2019-2022 |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $201.61 | 2022-2025 | Tezspire |
| Mallinckrodt Hospital Products INC. | $197.90 | 2023-2024 | Acthar |
| Baxter Healthcare | $137.85 | 2023-2025 | Hillrom - Monarch Airway Clearance System, Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| Vifor Pharma, INC. | $105.31 | 2024-2025 | Zemaira |
| Teva Pharmaceuticals USA, INC. | $82.15 | 2019-2023 | Airduo Digihaler |
| Sanofi-Aventis U.S. LLC | $78.99 | 2024 | |
| Avadel Cns Pharmaceuticals, LLC | $69.82 | 2025 | Lumryz |
| United Therapeutics Corporation | $52.57 | 2024-2025 | Tyvaso, Tyvaso |
| Sunovion Pharmaceuticals INC. | $51.03 | 2019 | |
| Axsome Therapeutics, INC. | $42.55 | 2023 | Sunosi |
| Nabriva Therapeutics, Plc | $40.64 | 2020-2022 | |
| Jazz Pharmaceuticals INC. | $32.70 | 2019 | |
| Viatris Specialty LLC | $31.35 | 2025 | Yupelri |
| Shire North American Group INC | $30.56 | 2019 | |
| Lilly USA, LLC | $25.00 | 2025 | Zepbound |
| Inogen, INC. | $22.25 | 2022 | |
| Itamar Medical INC | $20.69 | 2025 | Watchpatone |
| Eisai INC. | $17.40 | 2021 | |
| Novartis Pharmaceuticals Corporation | $15.89 | 2019 | |
| Fisher & Paykel Healthcare INC | $15.47 | 2019 | |
| Merck Sharp & Dohme LLC | $15.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vas Devan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.